| |
Adimab
Avedro
Bar Harbor Biotechnology
GlycoFi
M2S
PCD Partners |
Bar Harbor Biotech ("BHB") is a life sciences company spun-out from The Jackson Laboratory to develop gene expression products and services. BHB’s technology focuses on real-time quantitative polymerase chain reaction ("qPCR"), an established technique for gene expression used in disease research, molecular diagnostics, drug discovery, and other fields of biology research. BHB's prepared gene expression arrays, advanced computational tools and bioinformatics resources overcome the existing wet-lab and computational challenges of qPCR and make multi-gene qPCR analysis more affordable, convenient, accurate, and reliable than ever before. |
Bar Harbor Biotechnology, Inc.
18 Riverfield Road
Trenton, ME 04605
www.bhbio.com
Initial Investment: August 2006
CEO: Robert Phelps
|
|
